2021年美国心脏协会《儿童心肌炎的诊断和治疗科学声明》解读  

Interpretation of the 2021 American Heart Association scientific statement:diagnosis and management of myocarditis in children

作　　者：郑志豪 王本臻[1] 李自普[1] Zheng Zhihao;Wang Benzhen;Li Zipu(Heart Center,Qingdao Women and Children′s Hospital of Qingdao University,Qingdao 266034,Shandong Province,China;Department of Clinical Medicine,Qingdao Medical College,Qingdao University,Qingdao 266071,Shandong Province,China)

机构地区：[1]青岛大学附属妇女儿童医院心脏中心,山东青岛266034 [2]青岛大学青岛医学院临床医学系,山东青岛266071

出　　处：《中华实用儿科临床杂志》2021年第19期1452-1457,共6页Chinese Journal of Applied Clinical Pediatrics

摘　　要：儿童心肌炎的诊治及管理仍是儿科心血管医师面临的严峻挑战。2021年美国心脏协会总结了儿童心肌炎领域内现有的知识和治疗方法后,重新给出了儿童心肌炎的定义,强调了儿童心肌炎免疫发病机制、新的和不断变化的主要病因、现代实验室检测和机械循环支持使用方面认识的进步,特别强调了有关心脏磁共振成像的创新。现就其主要内容加以解读,以帮助广大儿科医师深入理解儿童心肌炎的诊治和随访管理。The diagnosis and management of myocarditis in children is a major challenge for pediatric cardiologists.In 2021,the American Heart Association redefined pediatric myocarditis after summarizing existing relevant information and treatment strategies for pediatric myocarditis,which emphasized the immunopathogenesis,new and conti-nuously changed main causes,modern laboratory testing methods and advances in the use of mechanical circulatory support.In particular,innovations of cardiac magnetic resonance in children myocarditis have been highlighted.The main contents of the statement to help pediatricians understand the diagnosis and management of myocarditis in children are interpreted.

关 键 词：心肌炎 诊断 治疗 儿童 

分 类 号：R725.4[医药卫生—儿科]